ARCELLX INC's ticker is and the CUSIP is 03940C100. A total of 138 filers reported holding ARCELLX INC in Q3 2023. The put-call ratio across all filers is 0.23 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $102,974,416 | +14.3% | 2,869,967 | +0.8% | 5.56% | +15.6% |
| Q2 2023 | $90,059,041 | +21.9% | 2,848,167 | +18.8% | 4.82% | +54.3% |
| Q1 2023 | $73,892,270 | +1.5% | 2,398,321 | +2.0% | 3.12% | +2.1% |
| Q4 2022 | $72,813,316 | +72.4% | 2,350,333 | +4.5% | 3.06% | +74.4% |
| Q3 2022 | $42,224,000 | -5.5% | 2,249,533 | -8.9% | 1.75% | +3.2% |
| Q2 2022 | $44,668,000 | +107.8% | 2,470,559 | +61.2% | 1.70% | +158.6% |
| Q1 2022 | $21,493,000 | – | 1,533,059 | – | 0.66% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SR ONE CAPITAL MANAGEMENT, LP | 3,946,630 | $141,605,084 | 72.57% |
| NEA Management Company, LLC | 3,745,262 | $134,380,001 | 10.38% |
| Paradigm Biocapital Advisors LP | 2,953,122 | $105,958,017 | 7.19% |
| Samsara BioCapital, LLC | 613,921 | $22,027,485 | 6.74% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 2,869,967 | $102,974,416 | 5.56% |
| Perceptive Advisors | 3,965,978 | $142,299,291 | 4.75% |
| Cormorant Asset Management, LP | 2,150,000 | $77,142,000 | 4.50% |
| Affinity Asset Advisors, LLC | 400,000 | $14,352,000 | 4.04% |
| Novo Holdings A/S | 1,075,000 | $38,571,000 | 2.85% |
| Soleus Capital Management, L.P. | 643,777 | $23,098,719 | 2.13% |